Literature DB >> 26064516

Fibronectin glomerulopathy.

Ikue Ishimoto1, Eisei Sohara1, Eisaku Ito2, Tomokazu Okado1, Tatemitsu Rai1, Shinichi Uchida1.   

Abstract

Fibronectin glomerulopathy occurs between the second and fifth decades of life in most patients, and it is known to be slowly progressive with mild proteinuria leading to kidney failure. The case of a 78-year-old woman with a rapid course of nephrotic syndrome due to fibronectin glomerulopathy is reported. She had proteinuria that rapidly increased to 6.8 g/day in a month and microscopic haematuria. A renal biopsy specimen showed lobular glomerulopathy and membranoproliferative glomerulonephritis-like lesions on light microscopy. There was scanty staining for immunoglobulins and complement. Electron microscopy revealed granular deposits with fibril formation. Immunohistochemistry of the fibronectin showed intense staining in the mesangium and peripheral loop. Therefore, this case was diagnosed as fibronectin glomerulopathy. The kidney function was rapidly decreasing, necessitating haemodialysis 2 months after renal biopsy. It is important to consider fibronectin glomerulopathy in the differential diagnosis of nephrotic syndrome in older people.

Entities:  

Keywords:  fibronectin glomerulopathy; haemodialysis; nephrotic syndrome

Year:  2013        PMID: 26064516      PMCID: PMC4438411          DOI: 10.1093/ckj/sft097

Source DB:  PubMed          Journal:  Clin Kidney J        ISSN: 2048-8505


Background

Fibronectin glomerulopathy is an autosomal-dominant renal disease. Common clinical features are mild proteinuria and varying degrees of haematuria, hypertension and slow progression to end-stage renal disease over 15–20 years [1]. A diagnosis is made only by renal biopsy. Electron microscopy shows abnormal electron-dense deposits in the mesangium and subendothelial zone. The deposits may be finely granular or have a fibrillary substructure with randomly arranged, 12- to 16-nm fibrils. The diagnosis of fibronectin glomerulopathy is confirmed when the intense staining for the plasma isoform of fibronectin is found in the mesangium and along the capillary walls [2, 3]. Currently, there is no specific treatment for fibronectin glomerulopathy.

Case report

A 78-year-old Japanese woman was admitted because of systemic oedema. Approximately 11 months earlier, her serum creatinine level was within the normal range (Cre 38.1 µmol/L), and her urinalysis was also normal at a medical check-up. Eight months earlier, non-steroidal anti-imflammatory drugs (NSAIDs) were prescribed for arthralgia. Six weeks before hospitalization, she visited us for the first time. Her serum creatinine was 101 µmol/L. Urinalysis showed proteinuria of 0.65 g/day and haematuria of 30–49 red blood cells/high-power field. The NSAIDs were discontinued, and after 2 weeks, the serum creatinine decreased to 68.6 µmol/L, although the urinalysis findings did not improve. One month later, she came to the outpatient clinic again because of systemic oedema. Urinalysis revealed proteinuria of 10.2 g/gCre (protein-creatinine ratio), and laboratory tests showed a serum total protein of 48 g/L, a serum albumin of 26 g/L and a serum creatinine of 101 µmol/L. She was diagnosed with nephrotic syndrome and was admitted. On admission, she had a blood pressure of 148/93 mmHg and her weight had increased 11 kg in a month. A percutaneous renal biopsy was performed for accurate diagnosis of her nephrotic syndrome. Light microscopy contained 40 glomeruli. Haematoxylin and eosin-stained sections showed massive, homogeneous, eosinophilic deposits in the mesangial space with formation of a lobular shape (Figure 1A). No crescent formation was seen. Capillary walls had double contours, and almost all glomeruli had numerous periodic acid-Schiff (PAS)-positive deposits in the mesangial space and between the double-contour capillary walls (Figure 1B and C). Amyloid staining and Congo-red staining were both negative. Immunofluorescence studies showed slight intensity of IgG in a peripheral pattern. However, other immunofluorescence microscopy tests were all negative. Electron microscopy revealed granular deposits in the mesangial space (Figure 1D). The granular deposits showed focal fibril formation with higher magnifications (Figure 1E). The fibrils were randomly arranged, with no central core, and their diameter was 12–14 nm. Fibronectin glomerulopathy was suspected because of this fibril formation and size. Therefore, plasma fibronectin immunostaining was performed. Immunohistochemistry of the fibronectin clearly showed intense staining in the mesangial space and a peripheral pattern (Figure 1F). Thus, the case was diagnosed as having fibronectin glomerulopathy based on these histological findings.
Fig. 1.

(A) Haematoxylin and eosin-stained section showed massive, homogeneous, eosinophilic deposits in the mesangium space with formation of a lobular shape (×300). (B) PAS stain. Capillary walls were with double contour (arrows) and almost all glomeruli had numerous PAS-positive deposits (arrowheads) in the mesangium space and between double contour capillary walls (×300). (C) Periodic acid silver methenamine stain. There were silver methenamine stain-negative and PAS-positive materials (arrows) in the mesangium space (×300). (D) Electron micrograph showed faint deposits in the mesangium space (arrows), not the typical electron-dense deposits, but granular deposits with focal fibril formation (×2800). (E) Electron micrograph at high magnification (×60 000). The deposits had fibrillary substructure, with randomly arranged, 12–14 nm fibrils. They had no central core. (F) Immunochemistry for plasma fibronectin showed intense staining in the mesangial and peripheral loop (×300).

(A) Haematoxylin and eosin-stained section showed massive, homogeneous, eosinophilic deposits in the mesangium space with formation of a lobular shape (×300). (B) PAS stain. Capillary walls were with double contour (arrows) and almost all glomeruli had numerous PAS-positive deposits (arrowheads) in the mesangium space and between double contour capillary walls (×300). (C) Periodic acid silver methenamine stain. There were silver methenamine stain-negative and PAS-positive materials (arrows) in the mesangium space (×300). (D) Electron micrograph showed faint deposits in the mesangium space (arrows), not the typical electron-dense deposits, but granular deposits with focal fibril formation (×2800). (E) Electron micrograph at high magnification (×60 000). The deposits had fibrillary substructure, with randomly arranged, 12–14 nm fibrils. They had no central core. (F) Immunochemistry for plasma fibronectin showed intense staining in the mesangial and peripheral loop (×300). She had progressive pre-renal acute kidney injury due to nephrotic syndrome. Two months after kidney biopsy, haemodialysis was started, and she became dialysis-dependent thereafter.

Discussion

A case of rapidly progressive nephrotic syndrome due to fibronectin glomerulopathy in an elderly woman that resulted in end-stage renal disease was described. Fibronectin glomerulopathy is an autosomal-dominant renal disease. However, the present patient family history was negative for kidney disease. As reported by other groups, she could be a sporadic case of fibronectin glomerulopathy. Castelletti et al. [4] sequenced the gene encoding fibronectin-1 (FN1) and found three heterozygous missense mutations, Y973C, W1925R and L1974R, which co-segregated with the disease in 40% of pedigrees. However, other families (60%) affected by fibronectin glomerulopathy showed no causative gene mutations in FN1. FN1 was sequenced in the present patient, but she did not have these missense mutations. Although it was reported that fibronectin glomerulopathy is uncommonly caused by systemic lupus erythematosus, this patient was negative for systemic lupus erythematosus [5]. In fibronectin glomerulopathy, most patients have mild proteinuria, microscopic haematuria, hypertension and slowly decreasing renal function over 15–20 years (Table 1). Only a small subset present with nephrotic-range proteinuria, although it is a slowly progressive proteinuria [6]. However, in the present patient, nephrotic syndrome occurred rapidly, and proteinuria increased to 6.8 g/day in a month. To the best of our knowledge, such a rapid clinical course of nephrotic syndrome has not been previously reported in fibronectin glomerulopathy.
Table 1.

Past case reports of fibronectin glomerulopathy

ReporterCase numbersAge at biopsy (years)Pcr at biopsy (µmol/L)Proteinuria (at biopsy)Renal outcome (Follow-up years)
Strom et al. [6]23 patients (6 families)14–5945.8–13721 patients: positive (9 patients: nephrotic)4 patients: HD (2,7,10,13 years)
Gemperle et al. [1]9 patients (1 family)20–46Not reported7 patients: positive, (1 patient: nephrotic)2 patients: HD (14, 14), 2 patients: CAPD (15,21 years)
Castelletti et al. [4]8 patients (1 family)12–5953.4–1686 patients: positive (4 patients: nephrotic), 2 patients: unknownHD(-) (max. follow-up: 23 years)
Uesugiet al. [7]5 patients (4 families)3–7515.3–1225 patients: positive (2 patients: nephrotic)HD(-) (max. follow-up: 10 years)
Sato et al. [8]1 patient2368.61–2 g/daynot reported
Niimi et al. [9]1 patient315.3NephroticPcr was stable (7 years)
Nadamuni et al. [10]1 patient5061.0NephroticPcr was stable (1 year)
Baydar et al. [11]1 patient2462.51 g/dayPcr was stable (2.5 years)
This Case1 patient7899.16.8 g/dayHD

Pcr, Plasma creatinine.

Past case reports of fibronectin glomerulopathy Pcr, Plasma creatinine. Fibronectin glomerulopathy is usually diagnosed between the second and fifth decades of life [6], and the oldest patient was 75 years old [7]. This case is interesting because proteinuria occurred at 78 years of age, the oldest onset of fibronectin glomerulopathy reported to date. Taken together, fibronectin gromerulopathy should be considered in the differential diagnosis of rapidly progressive nephrotic syndrome in elderly patients. Conflict of interest statement. None declared.
  11 in total

1.  Fibronectin glomerulopathy: an unusual cause of adult-onset nephrotic syndrome.

Authors:  Mridula Nadamuni; Rossella Piras; Sami Mazbar; John P Higgins; Neeraja Kambham
Journal:  Am J Kidney Dis       Date:  2012-06-20       Impact factor: 8.860

2.  [Fibrillary glomerulonephritis. Case report for differential nephrotic syndrome diagnosis].

Authors:  M Weiss; K Tzavella; J Müller-Höcker; A Nerlich; E Held
Journal:  Pathologe       Date:  1998-02       Impact factor: 1.011

3.  [Clinicopathological and morphometrical analysis of 5 cases from 4 families of fibronectin glomerulopathy].

Authors:  N Uesugi; R Katafuchi; H Taguchi; M Turu; N Sakata; S Takebayashi
Journal:  Nihon Jinzo Gakkai Shi       Date:  1999-04

4.  Familial glomerulopathy with giant fibrillar (fibronectin-positive) deposits: 15-year follow-up in a large kindred.

Authors:  O Gemperle; J Neuweiler; F W Reutter; F Hildebrandt; R Krapf
Journal:  Am J Kidney Dis       Date:  1996-11       Impact factor: 8.860

5.  Fibronectin glomerulopathy with nephrotic syndrome in a 3-year-old male.

Authors:  Kazuhiko Niimi; Noboru Tsuru; Noriko Uesugi; Shigeru Takebayashi
Journal:  Pediatr Nephrol       Date:  2002-05       Impact factor: 3.714

6.  Familial lobular glomerulopathy: first case report in Asia.

Authors:  H Sato; M Matsubara; R Marumo; J Soma; K Kurosawa; Y Taguma; T Saito
Journal:  Am J Kidney Dis       Date:  1998-06       Impact factor: 8.860

7.  Fibronectin non-amyloid glomerulopathy.

Authors:  Jim L Yong; Murray C Killingsworth; S Timothy Spicer; Xiao-Juan Wu
Journal:  Int J Clin Exp Pathol       Date:  2009-11-20

8.  A case of familial glomerulopathy with fibronectin deposits caused by the Y973C mutation in fibronectin.

Authors:  Dilek Ertoy Baydar; Aysun Aybal Kutlugun; Elena Bresin; Rossella Piras
Journal:  Am J Kidney Dis       Date:  2012-12-06       Impact factor: 8.860

9.  Mutations in FN1 cause glomerulopathy with fibronectin deposits.

Authors:  Federica Castelletti; Roberta Donadelli; Federica Banterla; Friedhelm Hildebrandt; Peter F Zipfel; Elena Bresin; Edgar Otto; Christine Skerka; Alessandra Renieri; Marta Todeschini; Jessica Caprioli; Rosa Maria Caruso; Rosangela Artuso; Giuseppe Remuzzi; Marina Noris
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-11       Impact factor: 11.205

10.  Glomerulopathy associated with predominant fibronectin deposits: a newly recognized hereditary disease.

Authors:  E H Strøm; G Banfi; R Krapf; A B Abt; G Mazzucco; G Monga; F Gloor; J Neuweiler; R Riess; P Stosiek
Journal:  Kidney Int       Date:  1995-07       Impact factor: 10.612

View more
  6 in total

1.  Extracellular Matrix in Kidney Fibrosis: More Than Just a Scaffold.

Authors:  Roman David Bülow; Peter Boor
Journal:  J Histochem Cytochem       Date:  2019-05-22       Impact factor: 2.479

Review 2.  Fibronectin glomerulopathy complicated with persistent cloaca and congenital esophageal atresia: a case report and literature review.

Authors:  Misaki Takii; Takaichi Suehiro; Aya Shima; Hideki Yotsueda; Satoshi Hisano; Ritsuko Katafuchi
Journal:  BMC Nephrol       Date:  2017-09-06       Impact factor: 2.388

3.  Fibrilo-Tactoid Glomerulonephritis: A Possible Novel Morphological Variant.

Authors:  Amaresh Vanga; Sandeep Magoon; Jolanta Kowalewska; Saad Mussarat
Journal:  Case Rep Nephrol Dial       Date:  2020-11-17

Review 4.  Nonsteroidal Mineralocorticoid Receptor Antagonism by Finerenone-Translational Aspects and Clinical Perspectives across Multiple Organ Systems.

Authors:  Peter Kolkhof; Robert Lawatscheck; Gerasimos Filippatos; George L Bakris
Journal:  Int J Mol Sci       Date:  2022-08-17       Impact factor: 6.208

Review 5.  Mechanotransduction through adhesion molecules: Emerging roles in regulating the stem cell niche.

Authors:  Ryan Lim; Avinanda Banerjee; Ritusree Biswas; Anana Nandakumar Chari; Srikala Raghavan
Journal:  Front Cell Dev Biol       Date:  2022-09-12

6.  The Amniotic Fluid Proteome Differs Significantly between Donor and Recipient Fetuses in Pregnancies Complicated by Twin-to-Twin Transfusion Syndrome.

Authors:  Sun Min Kim; Byoung Kyu Cho; Byoung Jae Kim; Ha Yun Lee; Errol R Norwitz; Min Jueng Kang; Seung Mi Lee; Chan Wook Park; Jong Kwan Jun; Eugene C Yi; Joong Shin Park
Journal:  J Korean Med Sci       Date:  2020-03-16       Impact factor: 2.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.